Want to see how your resume matches up to this job? A free trial of our JobsAI will help! With over 2,000 biopharma executives loving it, we think you will too! Try it now — JobsAI.
Do you have expertise in, and a passion for, the development and application of advanced epidemiology methods to ensure rigorous insights for patients? Would you like to apply your expertise to impact early and late oncology clinical development in an organization that follows the science and turns ideas into life-changing medicines?
To realize AstraZeneca oncology’s long-term strategic goals to leverage Real World Data to accelerate drug development, we seek a postdoctoral researcher to develop, adapt, and rigorously evaluate epidemiological methods for bias correction to ensure our study findings are relevant and comparable to clinical trials and ultimately fit to support FDA submissions.
The postdoc will design and implement several demonstration projects, testing approaches to correct or minimize the impact of various biases we encounter in our day-to-day use of claims, electronic health records, and multi-modal data. Results from these methods will be compared to AZ's status-quo analytic approaches and validated against historical clinical trials' SoC arms!
You will have the opportunity to formulate and address key scientific questions motivated by AstraZeneca’s oncology portfolio strategy. These questions will drive innovative research of broad interest to the pharmacoepidemiology and clinical-genomics scientific communities. You will produce high-impact publications on innovative research questions in the fields of pharmacoepidemiology and causal inference and simultaneously advance AstraZeneca’s use of RWE to accelerate and streamline drug development. Furthermore, you will have access to extensive sources of RWD and clinical trial data, and the support of teams with in-depth knowledge of data sources, clinical expertise, and mentorship from internal and external methods experts.
You’ll join a highly motivated, fast-paced team of epidemiologists and data scientists committed to rigorous research, bringing novel RWD insights to AstraZeneca’s Oncology pipeline. Your experience will be enriched through collaboration with a diverse internal community, including statistical innovation, applied data science, artificial intelligence, clinical teams, and the broader community of AstraZeneca postdocs. In addition to the team at AstraZeneca, you will have the opportunity to be mentored by two academic advisors, Dr. Issa Dahabreh from the T.H. Chan Harvard School of Public Health, and Dr. Camille Maringe at the London School of Hygiene and Tropical Medicine.
PhD in fields such as Epidemiology, Pharmacoepidemiology, Biostatistics, Statistical Genetics, Clinical Informatics, Computer Science, Health Informatics.